Methoxyhydroxyphenylglycol (3,4)
Talk0this wiki
Assessment |
Biopsychology |
Comparative |
Cognitive |
Developmental |
Language |
Individual differences |
Personality |
Philosophy |
Social |
Methods |
Statistics |
Clinical |
Educational |
Industrial |
Professional items |
World psychology |
Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology
| style="background: #F8EABA; text-align: center;" colspan="2" | Methoxyhydroxyphenylglycol (3,4) |
|---|---|
| 200px | |
| 1-(4-Hydroxy-3-methoxyphenyl) ethane-1,2-diol | |
| Identifiers | |
| CAS number | 67423-45-4 |
| PubChem | 10805 |
| MeSH | Methoxyhydroxyphenylglycol |
| SMILES | COC1=C(C=CC(=C1)C(CO)O)O |
| Properties | |
| Molecular formula | C9H12O4 |
| Molar mass | 184.18918 |
| Hazards | |
| style="background: #F8EABA; text-align: center;" colspan="2" | Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references |
Methoxyhydroxyphenylglycol (3,4) or 3-Methoxy-4-hydroxyphenylglycol (MHPG, MOPEG) is a metabolite of norepinephrine degradation. In the brain, it is the principal norepinephrine metabolite. It is released into the blood and cerebrospinal fluid,[1] and a blood sample of it may therefore be an indication of recent sympathetic nervous system activity.
References
Edit
- ↑ Increase in cerebrospinal fluid and plasma levels of 3-methoxy-4- hydroxyphenylglycol in acute stroke T Kanda, K Azuma, F Sakai and Y Tazaki. Department of Internal Medicine, School of Medicine, Kitasato University, Sagamihara, Japan.
Template:Neurotransmitter metabolism intermediates
| This page uses Creative Commons Licensed content from Wikipedia (view authors). |
